General Population

Surveying prospective population cohorts for COVID19 prevalence and outcomes in Canada (SUPPORT-Canada)

Philip Awadalla, Canadian Partnership for Tomorrow’s Health (CanPath)

Building on Canadian Partnership for Tomorrow’s Health (CanPath), a national population health research platform that follows the health of 330,000 Canadians, SUPPORT-Canada aims to capture data and biologics to help researchers and clinicians determine the factors that contribute to COVID-19 susceptibility and severity.
Research summary Study website

Seroprevalence study and cross-validation of high-throughput serological tests conducted by the COVID-19 Immunity Task Force (Héma-Québec)

Marc Germain, Héma-Québec

This study aims to estimate how many people have contracted the SARS-CoV-2 virus in Quebec or have antibodies to the virus due to vaccination. Researchers will do this by determining the prevalence of antibodies in a sample number of blood donors. The study testing periods correspond with the first and second waves of the pandemic in Quebec.
Research summary Results View study on

The Canadian COVID-19 Antibody and Health Survey (CCAHS)

Ron Gravel, Statistics Canada

Conducted by Statistics Canada, this survey aims to identify how many Canadians have been infected with SARS-CoV-2, the virus that causes COVID-19. Our study is the first to use a nationally representative sample to reflect COVID-19 seroprevalence across Canada at national, provincial, and territorial levels. This study is the first to use a nationally representative sample to reflect COVID-19 seroprevalence across Canada at national, provincial, and territorial levels.
Research summary View study on

Photo of Deborah Money

Canadian population serological survey utilizing antenatal serum samples

Deborah Money, University of British Columbia

Pregnant women undergo routine blood screening as part of prenatal care, and they are representative of generally healthy adults aged 18 to 45 across socioeconomic and cultural backgrounds. This study analyzes blood samples from expectant women across the country — to help determine the prevalence and spread of SARS-CoV-2 in Canada.
Research summary Study website View study on

Canadian Blood Services: Testing for SARS-CoV-2 infection in the general population

Sheila O’Brien, Canadian Blood Services

In this study, Canadian Blood Services aims to test approximately half a million samples from blood donors over a two-year period to provide data about COVID-19 infection rates in Canada. Samples will be monitored on a monthly basis using demographic and regional variables. Also, repeat donors will be tested multiple times to allow for longer-term tracking, and will possibly track how long immune responses to SARS-CoV-2 infection last.
Research summary Results View study on

See our other funded reseach studies

See our other funded reseach studies